The Latest Breaking News from Vaccine

Albert Bourla has already received four doses of the Pfizer-BioNTech vaccine

An Omicron-specific booster vaccination has been approved in the UK

Is it too soon for university courses that will teach us how to prepare for future pandemic shocks? 

Shingles can be severe and serious, and also hard to treat, particularly if not identified very early, writes Associate Professor Helen Petousis-Harris

Analysis: a bivalent vaccine has been approved and research is being carried out into possible pan-coronavirus vaccines

A single jab will be offered to eligible people including all adults aged 50 and above

Adults over 50 and clinically vulnerable people will be offered the first Covid-19 jab to target two strains of the virus, as part of the UK’s autumn booster programme.

The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms

Health Secretary Steve Barclay has said the vaccine will be part of the autumn booster programme.

The autumn booster program for Covid vaccinations will begin shortly. Over 50s, carers, frontline health workers and those at clinical risk will be inited to get a booster jab.

A “next generation” Covid-19 booster jab which is the first to target two strains of the virus has been approved for use in adults in the UK.The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Moderna’s bivalent vaccine, which targets both the original Covid strain and the Omicron variant.Known…